Skip to content

Cellfina Motor Module Device and Package CM1 Rev C, D, ERecalls & reported problems

Ulthera, Inc. · No change in DI justified in the CO. No form fit function, model or version changes triggering a new DI · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00840763100384), received between Oct 8, 2018 and Oct 8, 2018 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Scar Tissue1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 8, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON (B)(6) 2018, ULTHERA, INC., MERZ DEVICE INNOVATION CENTER BECAME AWARE VIA EMAIL OF A PATIENT WHO WAS EXPERIENCING "KELOID SCARRING" AT "ENTRY POINTS" FOLLOWING A CELLFINA TREATMENT PERFORMED ON (B)(6) 2018.

    Patient problems: Scar Tissue

    MAUDE report 7944859 ↗

Other Powered Surgical Instrument For Improvement In The Appearance Of Cellulite devices

All Powered Surgical Instrument For Improvement In The Appearance Of Cellulite devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page